Miltefosine-Induced Apoptotic Cell Death on Leishmania major and L. tropica Strains |
Khademvatan, Shahram
(Department of Medical Parasitology, Ahvaz Jundishapur University of Medical Sciences)
Gharavi, Mohammad Javad (Department of Medical Parasitology and Mycology, Faculty of Allied Medicine, Tehran University of Medical Sciences) Rahim, Fakher (Cellular and Molecular Research Center, Ahvaz Jundishapur University of Medical Sciences) Saki, Jasem (Department of Medical Parasitology, Ahvaz Jundishapur University of Medical Sciences) |
1 | Hadighi R, Boucher P, Khamesipour A, Meamar AR, Roy G, Ouellette M, Mohebali M. Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitol Res 2007; 101: 1319-1322. DOI ScienceOn |
2 | Esmaeili J, Mohebali M, Edrissian GH, Rezayat SM, Ghazi-Khansari M, Charehdar S. Evaluation of miltefosine against L. major (mrho/ir/75/er): in vitro and in vivo studies. Acta Med Iran 2008; 4: 191-196. |
3 | Arnoult D, Akarid K, Grodet A, Petit PX, Estaquier J, Ameisen JC. On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ 2002; 9: 65-81. DOI ScienceOn |
4 | Paris C, Loiseau PM, Bories C, Breard J. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother 2004; 48: 852-859. DOI ScienceOn |
5 | Wanderley JL, Barcinski MA. Apoptosis and apoptotic mimicry: the Leishmania connection. Cell Mol Life Sci 2010; 67: 1653-1659. DOI ScienceOn |
6 | Khademvatan S, Gharavi MJ, Akhlaghi L, Samadikuchaksaraei A, Oormazdi H, Mousavizadeh K, Hadighi R, Saki J. Induction of apoptosis by miltefosine in Iranian strain of Leishmania infantum promastigotes. Iranian J Parasitol 2009; 4: 23-31. |
7 | Lee N, Bertholet S, Debrabant A, Muller J, Duncan R, Nakhasi HL. Programmed cell death in the unicellular protozoan parasite Leishmania. Cell Death Differ 2002; 9: 53-64. DOI ScienceOn |
8 | Mukherjee SB, Das M, Sudhandiran G, Shaha C. Increase in cytosolic levels through the activation of non-selective cation channels induced by oxidative stress causes mitochondrial depolarization leading to apoptosis-like death in Leishmania donovani promastigotes. J Biol Chem 2002; 277: 24717-24727. DOI |
9 | Mohebali M, Edrissian GH, Nadim A, Hajjaran H, Akhoundi B, Hooshmand B, Zarei Z, Arshi A, Mirsamadi N, Naeini KM, Mamishi S, Sanati AA, Moshfe AA, Charehdar S, Fakhar M. Application of direct agglutination test (DAT) for the diagnosis and seroepidemiological studies of visceral leishmaniasis in the Islamic Republic of Iran. Iran J Parasitol 2006; 1: 15-25. |
10 | Momeni AZ, Aminjavaheri M. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol. Eur J Dermatol 2003; 13: 40-43. |
11 | Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 2006; 3: e162. DOI |
12 | Mishra BB, Kale RR, Singh RK, Tiwari VK. Alkaloids: future prospective to combat leishmaniasis. Fitoterapia 2009; 80: 81-90. DOI ScienceOn |
13 | Richard JV, Werbovetz KA. New antileishmanial candidates and lead compounds. Curr Opin Chem Biol 2010; 14: 447-455. DOI ScienceOn |
14 | Mohebali M, Fotouhi A, Hooshmand B, Zarei Z, Akhoundi B, Rahnema A, Razaghian AR, Kabir MJ, Nadim A. Comparison of miltefosime and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran. Acta Trop 2007; 103: 33-40. DOI ScienceOn |
15 | Verma NK, Dey CS. Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother 2004; 48: 3010-3015. DOI ScienceOn |
16 | Wortmann G, Hochberg L, Houng HH, Sweeney C, Zapor M, Aronson N, Weina P, Ockenhouse CF. Rapid identification of Leishmania complexes by a real-time PCR assay. Am J Trop Med Hyg 2005; 73: 999-1004. |
17 | Vaux DL. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993; 90: 786-789. DOI ScienceOn |
18 | Ameen M. Cutaneous and mucocutaneous leishmaniasis: emerging therapies and progress in disease management. Expert Opin Pharmacother 2010; 11: 557-569. DOI ScienceOn |
19 | Ellis RE, Yuan JY, Horvitz HR. Mechanisms and functions of cell death. Ann Rev Cell Biol 1991; 7: 663-698. DOI ScienceOn |
20 | Raff MC. Social controls on cell survival and cell death. Nature 1992; 356(6368): 397-400. DOI ScienceOn |
21 | Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267(5203): 1445-1449. DOI |
22 | Heussler VT, Küenzi P, Rottenberg S. Inhibition of apoptosis by intracellular protozoan parasites. Int J Parasitol 2001; 31: 1166-1176. DOI ScienceOn |
23 | McConkey DJ, Zhivotovsky B, Orrenius S. Apoptosis--molecular mechanisms and biomedical implications. Mol Aspects Med 1996; 17: 1-110. DOI ScienceOn |
24 | Hamann A, Brust D, Osiewacz HD. Apoptosis pathways in fungal growth, development and ageing. Trends Microbiol 2008; 16: 276-283. DOI ScienceOn |
25 | Wanderley JL, Benjamin A, Real F, Bonomo A, Moreira ME, Barcinski MA. Apoptotic mimicry: an altruistic behavior in host/Leishmania interplay. Braz J Med Biol Res 2005; 38: 807-812. DOI |
26 | Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501. DOI ScienceOn |
27 | Mohebali M, Javadian E, Yaghoobi-Ershadi MR, Akhavan AA, Hajjaran H, Abaei MR. Characterization of Leishmania infection in rodents from endemic areas of the Islamic Republic of Iran. East Mediterr Health J 2004; 10: 591-599. |